DemetriusMMaraganoreMDFAAN

PubMed

• 14 citations
  Early prediction of Alzheimer's disease and related dementias using real-world electronic health records.
  Qian Li, Xi Yang, Jie Xu, Yi Guo, Xing He
  Alzheimer's & Dementia. 2023-08-01
• 3042 citations
  α-Synuclein Locus Triplication Causes Parkinson's Disease
  Andrew B. Singleton, Matthew J. Farrer, Joshua C. Johnson, Amanda Singleton, Stephen Hague
  Science. 2003-10-31
• 66 citations
  Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies.
  Njideka U Okubadejo, James H. Bower, Walter A. Rocca, Demetrius M. Maraganore
  Movement Disorders. 2006-12-01

Journal Articles

• Structured Clinical Documentation to Improve Quality and Support Practice‐Based Research in Headache  
  Franco Campanella, Susan Rubin, Steven Meyers, Angela Mark, Demetrius M Maraganore, Thomas Freedom, Irene Semenov, Headache: The Journal of Head and Face Pain
• In Memorium - Nicholas A Vick, MD  
  McMahon JP, Groothuis DR, Homer D, Maraganore DM, Neurology, 1/10/2015
• Large Scale Assessment of Polyglutamine Repeat Expansions in Parkinson Disease  
  Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschlander A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjige..., Neurology, 1/9/2015
• Contemporary Issues in Neurological Practice – Quality Improvement and Practice-Based Research in Neurology Using the Electronic Medical Record  
  Maraganore DM, Frigerio R, Kazmi N, Meyers SL, Sefa M, Walters SA, Silverstein JC, Neurology Clinical Practice, 1/1/2015
• Role for the microtubule-associated protein tau variant pA152T in risk of A-synucleinopathies  
  Labbe C, Ogaki K, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Rayaprolu S, Fujioka S, Murray ME, Heckman MG, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, K..., Neurology, 1/1/2015
• MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies  
  Ross O, Labbe C, Heckman MG, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Murray ME, Allen M, Uitti RJ, Wszolek ZK, Smith GE, Kantarci K, Knopman D, Lowe VJ, Jack ..., Alzheimer’s and Dementia, 1/1/2015
• Genome-Wide Gene-Environment Interaction Analysis of Pesticide Exposure and Risk of Parkinson’s Disease  
  JM Biernacka JM, Chung SJ, Armasu SM, Anderson KS, Lill CM, Bertram L, Ahlskog JE, Brighina L, Frigerio R, Maraganore DM, JM Biernacka JM, Chung SJ, Armasu SM, Anderson KS, Lill CM, Bertram L, Ahlskog JE, Brighina L, Frigerio R, Maraganore DM, 1/1/2015
• Alpha-synuclein REP1 variants and survival in Parkinson's disease  
  Chung SJ, Biernacka J, Armasu S, Anderson K, Frigerio R, Aasly J, Annesi G, Bentivoglio AR, Brighina L, Chartier-Harlin MC, Goldwurm S, Hadjigeorgiou G, Jasinska-Myga..., Movement Disorders, 1/1/2014
• Does A-Synuclein Have A Dual and Opposing Effect in Preclinical versus Clinical Parkinson's Disease?  
  Markopoulou K, Biernacka J, Armasu S, Anderson K, Ahlskog JE, Chase B, Chung SJ, Cunningham J, Farrer M, Frigerio R, Maraganore D, Parkinsonsim and Related Disorders, 1/1/2014
• Lack of Replication of the GRIN2A-by-Coffee Interaction in Parkinson’s Disease  
  Ahmed I, Lee P-C, Lill CM, Nielsen SS, Artaud F, Gallagher LG, Loriot M-A, Mulot C, Nacfer M, Liu T, Biernacka JM, Armasu S, Anderson K, Farin FM, Lassen CF, Hansen J,..., PLOS Genetics, 1/1/2014
• Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson’s Disease (GEO-PD) consortium  
  Heckman MG, MS1, Alexandra I. Soto-Ortolaza AI, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Carr J, Chartier-Harlin M-C, Dardiotis..., Movement Disorders, 1/1/2013
• Genetic susceptibility loci, environmental exposures and Parkinson’s disease: a case-control study of gene-environment interactions  
  Chung SJ, Armasu SM, Anderson KJ, Biernacka JM, Lesnick TG, Rider, DN, Cunningham JM, Ahlskog JE, Frigerio R, Maraganore, DM, Parkinsonism and Related Disorders, 1/1/2013
• 'The Protective Effect of LRRK2 pR1398H on Risk of Parkinson's Disease is Independent of MAPT and SNCA Variants  
  Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin M-C, Dardiotis E, D..., Neurobiology of Aging, 1/1/2013
• Evidence for a Dual and Opposing Effect of alpha-Synuclein Genetic Variation in Preclinical versus Clinical Parkinson’s Disease  
  Markopoulou K, Biernacka J, Armasu S, Anderson K, Ahlskog JE, Chase B, Chung SJ, Cunningham J, Farrer M, Frigerio R, Maraganore DM, Brain, 1/1/2013
• Global investigation of the C9orf72 (G4C2)n hexanucleotide repeat reveals a role in Parkinson disease susceptibility  
  Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Crosiers D, Corsmit E, Elinck E, Sharma M, Krüger R, Lesage S, Brice A, Chung SJ, Kim M-I, Kim YJ, Ross O..., The Lancet Neurology, 1/1/2013
• Mutations in ClZ1 cause adult-onset primary cervical dystonia  
  Xiao J, Uitti R, Zhao Y, Vemula SR, Perlmutter JS, Wszolek ZK, Maraganore DM, Auburger G, Leube B, Lehnhoff K, LeDoux MS, Annals of Neurology, 1/1/2012
• Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: The PDGene Database  
  Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide B-MM, Schjeide LM, Meissner E, Zauft U, Allen, NC, Beecham G, Berg D, Brice A, DeStefano AL, Do CB, Erik..., PLoS Genetics, 1/1/2012
• Genomic Determinants of Motor and Cognitive Outcomes in Parkinson’s Disease  
  Chung SJ, Armasu S, Biernacka J, Anderson K, Lesnick T, Rider D, Cunningham J, Ahlskog JE, Frigerio R, Maraganore DM, Parkinsonism and Related Disorders, 1/1/2012
• Translation Initiator eIF4G1 mutations in familial Parkinson disease  
  Chartier-Harlin M-C, Dachsel JC, Vilariño-Güell C, Lincoln SJ, Hulihan MM, Kachergus J, Leprêtre F, LeRhun E, Mutez E, Larvor L, Ross OA, Nishioka K, Soto-Ortolaza AI,..., The American Journal of Human Genetics, 1/9/2011
• Variants in estrogen-related genes and risk of Parkinson’s disease  
  Chung SJ, Armasu SM, Biernacka JM, Lesnick TG, Rider DN, Cunningham JM, Maraganore DM, Movement Disorders, 1/1/2011
• Common Variants in PARK Loci and Related Genes and Parkinson's Disease  
  Chung SJ, Armasu SM, Biernacka JM, Lesnick TG, Rider DN, Lincoln SJ, Ortolaza AI, Farrer MJ, Cunningham JM, Rocca WA, Maraganore DM, Movement Disorders, 1/1/2011
• Perimenopausal Risk Factors and Future Health  
  The ESHRE Capri Workshop Group, Human Reproduction Update, 1/1/2011
• Incidental Lewy Body Disease: Do Some Cases Represent a Preclinical Stage of Dementia with Lewy Bodies?  
  Frigerio R, Fujishiro H, Ahn T-B, Josephs KA, Maraganore DM, DelleDonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE, Neurobiology of Aging, 1/1/2011
• Independent and joint effects of the MAPT and SNCA genes in Parkinson’s disease  
  Elbaz A, Ross OA, Ioannidis JPA, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin M-C, Destee A, Ferrarese C, Ferraris A, Gibson JM, ..., Annals of Neurology, 1/1/2011
• Do Interactions Between SNCA, MAPT, and LRRK2 Genes Contribute to Parkinson’s Disease Susceptibility?  
  Biernacka J, Armasu S, Cunningham J, Ahlskog JE, Chung SU, Maraganore D, Parkinsonism and Related Disorders, 1/1/2011
• Join now to see all

Books/Book Chapters

• Parkinson's Disease and Movement Disorders 
  Chapter: Epidemiology and Genetics of Parkinson's Disease 
  Maraganore DM, Adler CH, Ahlskog JEHumana Press, Totowa NJ2000

Abstracts/Posters

• Data Collection and Principal Component Analysis in Migraine Without and With Aura: A Practical Method of Combining Patient Care with Outcomes Research
  Freedom T, Meyers S, Rubin S, Semenov I, Mark A, Walters S, Frigerio R, Maraganore D, Headache: The Journal of Head and Face Pain, Special Issue: 57th Annual Scientific Meeting of the American Headache Society, 1/1/2015
• Automated Segmentation of Substantia Nigra - Improved Reliability for Multiparametric MR Measurements
  Hutten R, Desai N, Maraganore D, Edelman RR, Wu Y, Proceedings of the  23rd Annual Meeting of the International Society for Magnetic Resonance in Medicine, Milan, Italy, 1/16/2014
• Reliable Analysis of Tract-specific Multiparametric MR Data via Automated Isolation of Nigro-striatal Tract
  Hutten R, Desai N, Maraganore D, Edelman RR, Wu Y, Proceedings of the  23rd Annual Meeting of the International Society for Magnetic Resonance in Medicine, Milan, Italy, 1/16/2014
• Evaluation of the Genetic Contribution of Omi/HtrA2 to Parkinson's Disease in an International Collaborative Study
  Kruger R, Sharma M, Riess O, vanBroeckhoven C, Maraganore DM, Aasly J, Annesi G, Bentivoglio AR, Brice A, Elbaz A, Farrer M, Ferrarese C, Ferraris A, Hadjigeorgiou G, ..., Movement Disorders, Tuebingen, Germany, 1/1/2009
• Reduced Bowel Movements Preceding Parkinson's Disease: A Case-Control Study
  Savica R, Grossardt BR, Carlin JM, Bower JH, Ahlskog JE, Maraganore DM, Rocca WA, Movement Disorders, 1/1/2009
• Prospective Differentiation of Multiple System Atrophy from Parkinson's Disease
  Lipp A, Paola S, Eric A, Fealey RD, Gehrking TL, Weigand SD, Sletten DM, Gehrking JA, Nickander KK, Singer W, Maraganore DM, Wenning GK, Shults CM, Low PA, Movement Disorders, 1/1/2009
• Novelty Seeking Personality Traits Do Not Influence the Risk of Parkinson's Disease
  Arabia G, Grossardt BR, Colligan RC, Bower JH, Maraganore DM, Ahlskog JE, Rocca WA, Movement Disorders, 1/1/2009
• Cigarette smoking, CYP2A6 gene variants, and Parkinson’s Disease: A Case-Control Study
  Facheris MF, Schneider NK, Lesnick TG, de Andrade M, Kost LJ, Cunningham JM, Rocca WA, Maraganore DM, Movement Disorders, 1/1/2008
• Secondary Parkinsonism and a Distorted Midbrain
  Claassen DO, Burnett MS, Huston J, Maraganore DM, Movement Disorders, 1/1/2008
• Joint Effects of Alpha-Synuclein and Beta-Synuclein Genes in Parkinson's Disease
  Brighina L, Okubadego NU, Schneider NK, Lesnick TG, de Andrade M, Cunningham JL, Farrer MJ, Rocca WA, Maraganore DM, Neurology, 1/1/2007
• Increased Risk of Anxiety, Depression, and Other Psychiatric Disorders in Relatives of Patients with Parkinson's Disease: A Population-Based Cohort Study
  Arabia G, Bower JH, Ahlskog JE, Maraganore DM, Geda YE, Grossardt BR, Carlin JM, Rocca WA, Neurology, 1/1/2007
• Multiregional High-Throughput Gene Expression Profiling of Braak Regions in Parkinson's Disease
  Papapetropoulos S, Maraganore DM, Ffrench-Mullen J, McCorquodale D, Adi N, Mash DC, Neurology, 1/1/2007
• Alcoholism, Alpha-Synuclein, and Parkinson Disease: A Case-Control Study
  Brighina L, Schneider NK, Lesnick TG, de Andrade M, Cunningham JM, Farrer MJ, Lincoln SJ, Mrazek D, Rocca WA, Maraganore DM, Parkinson’s Disease and Related Disorders, 1/1/2007
• Increased Risk of Depressive and Anxiety Disorders in Relatives of Patients with Parkinson’s Disease
  Arabia G, Grossardt BR, Geda YE, Carlin JM, Bower JH, Ahlskog JE, Maraganore DM, Rocca WA, Parkinson’s Disease and Related Disorders, 1/1/2007
• Collaborative-pooled analysis of alpha-synuclein REP1 variability and Parkinson's disease
  Maraganore DM, American Academy of Neurology, San Francisco, CA, 1/1/2006
• The Mayo Clinic Cohort Study of Oophorectomy and Aging: Design and Follow-Up Description
  Grossardt BR, Bower JH, de Andrade M, Maraganore DM, Melton, LJ, Rocca WA, Neuroepidemiology, 1/1/2006
• Collaborative-Pooled Analysis of alpha-Synuclein REP1 Variability and Parkinson's Disease (PD)
  WA, Schneider N, LEsnick T, Aasly J, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick G, ..., Neurology, 1/1/2006
• Variants in Genes in the Estrogen Synthesis and Responsiveness Pathway and Risk of Parkinson's Disease: A Case-Control Study in Women
  Rocca WA, Grossardt B, de Andrade M, Bower JH, Maraganore DM, Neurology, 1/1/2006
• The Mayo Clinic Cohort Study of Oophorectomy and Aging: Results for Dementia and Cognitive Impairment
  Rocca W, Grossardt B, Ahlskog E, Bower J, de Andrade M, Maraganore DM, Neurology, 1/1/2006
• Education, Physically Demanding Occupations, and the Risk of Parkinson's Disease
  Frigerio R, Bower J, Ahlskog E, Grossardt B, de Andrade M, Maraganore DM, Rocca WA, Neurology, 1/1/2006
• High-Resolution Whole-Genome Association Study of Age at Onset Modifier Genes and Parkinson's Disease
  Maraganore DM, de Andrade M, Lesnick T, Farrer M, Rocca W, Neurology, 1/1/2006
• A novel LRRK2 mutation in a common cause of autosomal dominant parkinsonism in families from several European populations
  Toft M, Kachergus J, Mata IF, Hulihan M, Aasly J. Farrer M, Maraganore DM, Mov Disord, 1/1/2005
• Parkinson's disease in Africa: a systematic review
  Okubadejo NU, Bower JH, Rocca WA, Maraganore DM, Mov Disord, 1/1/2005
• Discordant Sibling Analyses Confirm the Association of UCHL1 with Parkinson’s Disease
  Maraganore DM, Facheris M, Lesnick TG, Strain KJ, de Andrade M, Cunningham JM, Rocca WA, Neurology, 1/1/2005
• Interaction of Alpha-Synuclein and Tau Genotypes in Parkinson’s Disease
  Maraganore DM, Mamah CE, Lesnick TG, Strain KJ, de Andrade M, Rocca WA, Farrer MJ, Neuroepidemiology, 1/1/2005
• Join now to see all

Lectures

• Paradigm Shift: from Brain Disorders to Brain Health 
  1/27/2015
• Quality Improvement and Practice Based Research in Neurology Using the Electronic Medical Record 
  1/18/2015
• Genetic Epidemiology of Parkinson’s Disease Consortium Updates 
  Vancouver, Canada - 1/1/2014
• The LONG-PD Study: Longitudinal Clinical and Genetic Study of Parkinson’s Disease 
  Vancouver, Canada - 1/1/2014
• Clinical and Research Informatics in Neurology: the DodoNA Project 
  1/24/2013
• Genetic Epidemiology of Parkinson’s Disease Consortium 
  Luebeck, Germany - 1/1/2013
• Research Electronic Data Capture and Sharing of Outcomes Data and DNAs in PD 
  Luebeck, Germany - 1/1/2013
• SNCA reduced expression genotypes and survival in PD 
  Multiple Locations, 2010, 2011, 2012 - 1/1/2012
• Datablitz Presentation 
  Multiple Locations, 2009, 2010, 2012 - 1/1/2012
• Introduction to GEO-PD 
  Multiple Locations, 2009, 2010, 2011, 2012 - 1/1/2012
• Back to the Future: from Greek Oracles to DNA Prediction 
  Seoul, Korea - 1/1/2012
• Lifestyles and the Aging Brain: the Example of Parkinson’s Disease 
  Capri, Italy - 1/30/2010
• Rationale for Targeting Alpha-Synuclein in Parkinson's Disease 
  Monza, Italy - 1/15/2010
• The DodoNA Project: Development of DNA-based Prognostics and Therapeutics for Neurological Diseases 
  Seoul, South Korea - 1/1/2010
• New Insights in Understanding and Treating Parkinson’s Disease: Rationale for Targeting alpha-Synuclein 
  Busan, Korea - 1/1/2010
• Genomic Determinants of Motor and Cognitive Outcomes in Parkinson's Disease 
  Lombardy, Italy - 1/1/2009
• Pathways to complexity: genomic pathway studies in PD 
  Trondheim, Germany - 1/1/2009
• Pathways to Complexity: The Examples of Parkinson's Disease, Alzheimer's Disease, and ALS 
  1/1/2009
• Genetics of Complex and Common Disorders 
  Seattle, WA - 1/1/2009
• The Genetic Epidemiology of Parkinson's Disease Consortium and Pathways-Based Analyses of PD GWA Datasets 
  Washington, DC - 1/24/2008
• Genomic Pathways, Environmental Exposures, and Disease Susceptibility: The Example of Parkinson’s Disease 
  Boston, MA - 1/16/2008
• Overview of the Genetic Epidemiology of Parkinson’s Disease Consortium 
  Trondheim, Norway - 1/1/2008
• GEO-PD Data Blitz 
  Trondheim, Norway - 1/1/2008
• Pathways to Complexity 
  Trondheim, Norway - 1/1/2008
• Paradigm Shift: From Single Gene to Pathway Studies of Complex Traits (The Example of Parkinson's disease) 
  Monza, Italy - 1/10/2007
• Join now to see all